Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001047469-18-003295
Filing Date
2018-04-27
Accepted
2018-04-27 16:14:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 a2235494z424b3.htm 424B3 87810
2 G349475.JPG g349475.jpg GRAPHIC 18430
  Complete submission text file 0001047469-18-003295.txt   114403
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-219736 | Film No.: 18784032
SIC: 2834 Pharmaceutical Preparations